$129 Million is the total value of Velan Capital Investment Management LP's 27 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | JASPER THERAPEUTICS INC | $22,945,000 | – | 3,219,036 | +100.0% | 17.81% | – | |
| LNTH | New | LANTHEUS HLDGS INC | $17,962,000 | – | 621,753 | +100.0% | 13.94% | – |
| New | SCIENCE 37 HOLDINGS INC | $14,964,000 | – | 1,200,000 | +100.0% | 11.61% | – | |
| IMCR | New | IMMUNOCORE HLDGS PLCads | $10,046,000 | – | 293,385 | +100.0% | 7.80% | – |
| ITCI | New | INTRA-CELLULAR THERAPIES INCcall | $7,851,000 | – | 150,000 | +100.0% | 6.09% | – |
| ADMA | New | ADMA BIOLOGICS INC | $7,611,000 | – | 5,397,798 | +100.0% | 5.91% | – |
| New | THE ONCOLOGY INSTITUTE INC | $5,850,000 | – | 600,000 | +100.0% | 4.54% | – | |
| NMTR | New | 9 METERS BIOPHARMA INC | $4,236,000 | – | 4,328,306 | +100.0% | 3.29% | – |
| New | NYXOAH S A | $4,087,000 | – | 177,679 | +100.0% | 3.17% | – | |
| RAPT | New | RAPT THERAPEUTICS INC | $4,040,000 | – | 110,000 | +100.0% | 3.14% | – |
| TELA | New | TELA BIO INC | $3,840,000 | – | 300,000 | +100.0% | 2.98% | – |
| New | CARIBOU BIOSCIENCES INC | $3,179,000 | – | 210,695 | +100.0% | 2.47% | – | |
| CFMS | New | CONFORMIS INC | $3,172,000 | – | 4,166,607 | +100.0% | 2.46% | – |
| New | SOMALOGIC INC | $2,739,000 | – | 235,300 | +100.0% | 2.13% | – | |
| CMRX | New | CHIMERIX INC | $2,572,000 | – | 400,000 | +100.0% | 2.00% | – |
| CSU | New | SONIDA SENIOR LIVING INC | $2,360,000 | – | 82,832 | +100.0% | 1.83% | – |
| HCSG | New | HEALTHCARE SVCS GROUP INC | $2,188,000 | – | 123,000 | +100.0% | 1.70% | – |
| MEIP | New | MEI PHARMA INC | $1,997,000 | – | 747,768 | +100.0% | 1.55% | – |
| RDUS | New | RADIUS HEALTH INC | $1,905,000 | – | 275,281 | +100.0% | 1.48% | – |
| RZLT | New | REZOLUTE INC | $1,434,000 | – | 300,000 | +100.0% | 1.11% | – |
| New | XERIS BIOPHARMA HOLDINGS INCcall | $1,308,000 | – | 446,500 | +100.0% | 1.02% | – | |
| CRIS | New | CURIS INC | $1,190,000 | – | 250,000 | +100.0% | 0.92% | – |
| New | GRAF ACQUISITION CORP IV | $836,000 | – | 86,506 | +100.0% | 0.65% | – | |
| New | ENVVENO MEDICAL CORPORATION | $491,000 | – | 74,478 | +100.0% | 0.38% | – | |
| GFORWS | New | GRAF ACQUISITION CORP IV*w exp 05/31/202 | $23,000 | – | 20,000 | +100.0% | 0.02% | – |
| BBIO | New | BRIDGEBIO PHARMA INC | $19,000 | – | 1,125 | +100.0% | 0.02% | – |
| New | SOMALOGIC INC*w exp 08/31/202 | $7,000 | – | 2,060 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LANTHEUS HLDGS INC | 8 | Q3 2023 | 18.0% |
| ADMA BIOLOGICS INC | 8 | Q3 2023 | 13.7% |
| JASPER THERAPEUTICS INC | 8 | Q3 2023 | 17.8% |
| TELA BIO INC | 8 | Q3 2023 | 7.6% |
| REZOLUTE INC | 8 | Q3 2023 | 1.3% |
| OPTINOSE INC | 7 | Q3 2023 | 7.9% |
| IMMUNOCORE HLDGS PLC | 6 | Q1 2023 | 13.7% |
| ALIMERA SCIENCES INC | 6 | Q3 2023 | 34.0% |
| QUIPT HOME MEDICAL CORP | 6 | Q3 2023 | 4.8% |
| SONIDA SENIOR LIVING INC | 6 | Q1 2023 | 2.5% |
View Velan Capital Investment Management LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-03-28 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-09 |
| SC 13D/A | 2024-02-09 |
| SC 13G/A | 2024-01-29 |
| 13F-HR | 2023-11-13 |
| 4 | 2023-10-04 |
| 4 | 2023-08-17 |
| SC 13D/A | 2023-08-16 |
| 13F-HR | 2023-08-11 |
View Velan Capital Investment Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.